FBLN2 and lung carcinoma: In addition to DNA methylation, histone acetylation might also play a role in the downregulation of FBLN2, since enhanced levels of FBLN2 were also detected in six out of nine lung cancer cell lines after treatment with TAS, a histone deacetylase inhibitor.